| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |